SCROLL
Our Mission

Our Mission

Connecting capital, businesses, and communities to create fundamental solutions for important problems.

We invest in companies and assets that can create value and grow by providing commercial solutions to key challenges faced by the world. Our goal is to support them to transform them into environmental and social impact contributors.

Purpose

We invest
with purpose

The Sylvan Group invests in companies to drive sustainable changes by providing innovative solutions that are built on strong environmental, social and governance (“ESG”) foundations.

We aim to deliver strong investment returns while creating positive value for the society and environment aligned with the United Nations Sustainability Development Goals (“UNSDG”).

Our strength

The Sylvan Group aims to deliver superior investment returns while creating positive value for our society and the planet.
Our leadership team is dedicated to making a positive impact by combining our robust investment management with the relevant industry expertise.

  • A highly
    experienced
    investment team

    Our investment team comprises of highly experienced professionals with strong investment track record across the regions we focus on. Our investment philosophy is guided by distinctive disciplines and fundamentals along with our team’s collective intellectual capital to deliver consistent returns through various business cycles.

  • Expansive local
    networks and
    knowledge

    Our network of experts and local teams in the Asia Pacific region plays a vital role to connect companies seeking a value-adding partner beyond just capital. Through our extensive network, we are able to identify unique opportunities in advance and capitalize on high conviction themes and sectors.

  • Global leaders
    in impact and
    sustainability

    Sylvan is co-founded and led by the strong proponents of ESG and impact investing. Kyungsun Chung (Managing Partner) and Valerie Rockefeller (Vice Chairman) share a strong belief that the ESGI investing is a powerful means for creating a more sustainable future and contributing towards real change. Both Kyungsun and Valerie are prominent thought leaders in ESGI and they instill a strong stewardship across our investment process and underwriting.

  • A highly experienced investment team

    Our investment team comprises of highly experienced professionals with strong investment track record across the regions we focus on. Our investment philosophy is guided by distinctive disciplines and fundamentals along with our team’s collective intellectual capital to deliver consistent returns through various business cycles.

  • Expansive local networks and knowledge

    Our network of experts and local teams in the Asia Pacific region plays a vital role to connect companies seeking a value-adding partner beyond just capital. Through our extensive network, we are able to identify unique opportunities in advance and capitalize on high conviction themes and sectors.

  • Global leaders in impact and sustainability

    Sylvan is co-founded and led by the strong proponents of ESG and impact investing. Kyungsun Chung (Managing Partner) and Valerie Rockefeller (Vice Chairman) share a strong belief that the ESGI investing is a powerful means for creating a more sustainable future and contributing towards real change. Both Kyungsun and Valerie are prominent thought leaders in ESGI and they instill a strong stewardship across our investment process and underwriting.

Our commitments for
sustainable world

The Sylvan Group is a thematic investment firm with distinct disciplines, working to deliver upper quartile investment returns through innovative and sustainable solutions in Asia Pacific.
We run a multi-country and multi-industry fund investing in “double-bottom line” business driven by megatrends and United Nations Sustainable Development Goals (“UNSDG”).

Sylvan SFDR Statement
Sustainability at the Core

Sustainability at the Core

It is not enough to simply have ESG risk considerations in our investments. To create a lasting and sustainable world, we focus on the investee company’s environmental and social impact potential. This is closely integrated into our investment practices focusing on three themes:
1) Climate and Environmental Action, 2) Inclusive Growth, and
3) Innovation for Sustainable Life.

ESG and Impact support for our portfolio

ESG and Impact support for our portfolio

Embedding ESG factors into a portfolio company’s business operation is our core mission. We regularly measure and assess ESG and its impact with KPI indexes and support their ESG transformation through ongoing monitoring and consultation.

Sylvan at glance

The Sylvan Group is

The Sylvan Group is an independent private investment firm with an experienced team. We have been successfully investing in middle-market companies across Asia Pacific for 20 years. A licensed fund manager with the Monetary Authority of Singapore (MAS), we drive sustainable change through empowering companies to make a difference.

Investment Team Location
Singapore, Seoul
Fund Status
Fundraising
Fund Currency
USD
Target Fund Size
US$ 400~600 Million
Term
10th Anniversary of the Final Closing Date
Investment Period
5th Anniversary of the Final Closing Date
  • Juniper Biologics
  • SL
  • PRI
  • Artemis Healthcare
  • GOALS

Recent Highlights

Learn More
Sylvan buys Singapore orthopaedics business

Sylvan buys Singapore orthopaedics business

Singapore-based private equity firm Sylvan Group has taken a controlling position in Singapore Orthopaedic Specialists (SOS) as a bolt-on of recently acquired Artemis Health Ventures. Sylvan purchased Artemis, a musculoskeletal care provider, in February along with three other healthcare companies. These four acquisitions, worth a combined USD 140.5m, were the firm’s first investments.... View Articles

The US and Asian family dynasties invest in a private equity group, Sylvan Group, which focuses on t

The US and Asian family dynasties invest in a private equity group, Sylvan Group, which focuses on t

A private equity firm’s unit – backed by the Rockefeller and Hyundai dynasties – has completed its growth partnership with Singapore Orthopaedic Specialists (SOS), which focuses on musculoskeletal care. The unit is called Artemis Health Ventures, part of the Sylvan Group. (This news service has also covered events at the Sylvan Group here.) Through the partnership, SOS will help its growth by bringing together medical professionals from across sub-specialities to provide the best-possible integrated musculoskeletal care in Singapore, it said in a statement. SOS operates under three practices – Orthopaedics International, Sports Medicine International and Neurosurgery International. The planned expansion comes at a time when demand for such care is increasing rapidly due to the ageing population. SOS’s practices treat patients suffering from various musculoskeletal ailments such as nagging sports injuries, spine and neurosurgical problems, ...

Sylvan Group’s Artemis Health Ventures seals strategic partnership with Singapore Orthopaedic Specia

Sylvan Group’s Artemis Health Ventures seals strategic partnership with Singapore Orthopaedic Specia

Artemis Health Ventures, a unit of The Sylvan Group, a private equity firm backed by members of the Hyundai and Rockefeller families, said today that it has completed its strategic growth partnership with Singapore Orthopaedic Specialists (SOS). Through the partnership, SOS will be able to accelerate the growth of its practices by bringing together talented medical professionals from across all relevant sub-specialties to provide the best possible integrated musculoskeletal care in Singapore. SOS operates under three practices – Orthopaedics International, Sports Medicine International and Neurosurgery International – and the planned expansion comes at a time when demand for such care is increasing rapidly due to the aging population. SOS’s practices treat patients suffering from various musculoskeletal ailments such as nagging sports injuries, spine and neurosurgical problems, musculoskeletal tumours, orthopaedic trauma, and painful arthritis. By working close...

Hyundai Scion’s Buyout Firm Invests $140.5 Million In Four

Hyundai Scion’s Buyout Firm Invests $140.5 Million In Four

Sylvan Group—the private equity firm cofounded by Chung Kyungsun, a grandson of Hyundai Group founder Chung Ju-Yung—is investing $140.5 million to take majority

Sylvan Group puts US$140.5m in 4 local healthcare and pharmaceutical

Sylvan Group puts US$140.5m in 4 local healthcare and pharmaceutical

The Sylvan Group has invested US$140.5 million in 4 Singapore healthcare and pharmaceutical companies in the first 4 deals for its maiden fund, Sylvan Growth Asia Growth Fund